secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2023-04-18T23:59:59+00:00
Accession:  0001193125-23-105074
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen amends bylaws to change 'Chairman' title to 'Chair'
----------------------------------------------------------

- Board approved Fourth Amended and Restated Bylaws effective April 12, 2023.
- Title change from 'Chairman' to 'Chair' adopted in corporate governance documents.
- No impact on financial position, operations, or leadership roles beyond nomenclature.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312523105074/0001193125-23-105074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312523105074/d500907d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-105074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer